[ Price : $8.95]
An FDA safety alert on certain diabetes devices that rely on a smartphone to deliver critical safety alerts warns that these may m...[ Price : $8.95]
A Bloomberg Law report says New York is the latest state to indicate an interest in the FDA pathway to import lower-cost drugs fro...[ Price : $8.95]
Kura Oncology and Kyowa Kurin say they expect to submit a ziftomenib NDA to FDA in the second quarter of 2025.[ Price : $8.95]
FDA grants Acrivon Therapeutics a breakthrough device designation for the ACR-368 OncoSignature assay, a multiplex immunofluoresce...[ Price : $8.95]
Baxter Healthcare Corporation recalls its Life2000 Ventilator System due to a nonconforming battery charger.[ Price : $8.95]
Novo Nordisk says a recent Phase 2 trial of monlunabant in diabetic kidney disease patients failed to meet its primary endpoint.[ Price : $8.95]
FDA warns Chinas Imperial Palace Commodity about CGMP violations in its manufacturing of over-the-counter drugs.[ Price : $8.95]
FDA warns Pompano Beach, FL-based BioStem Life Sciences that it is illegally marketing cellular products that also reflect CGMP vi...